CardioFunXion, the first European industrial PhD programme, coordinated by UPF with the company Philips
CardioFunXion, the first European industrial PhD programme, coordinated by UPF with the company Philips
CardioFunXion is a European industrial doctorate programme (EID) within the Marie Sklodowska-Curie actions, in the Horizon 2020 Framework Programme for Research and Innovation. It is co-directed by Bart Bijnens, head of the PhySense research group, and ICREA researcher of the Department of Information and Communication Technologies (DTIC), together with Mathieu Craene, of the company Philips Research France, Medysis. In addition, it has the collaboration of the Pi i Sunyer Biomedical Research Institute (IDIBAPS) in Barcelona, and Caen University Hospital Centre (Normandy, France), as clinical partners in the project.
This EID, a pioneering programme that gives the opportunity to pursue a doctoral academic career in collaboration with European companies, is the first obtained by UPF and one of the few that exist in Spain.
Thanks to the CardioFunxion programme, researchers in the initial stages will acquire multidisciplinary skills with cutting-edge technology to develop advanced imaging techniques for the assessment of cardiovascular disorders. Is articulated around a platform of clinical, academic and industrial collaboration, and establishes sustainable partnerships for the achievement of more efficient and controllable clinical imaging interpretation tools for clinical application. In addition to the scientific skills, the doctoral students will acquire skills and experience in commercial development in an area in which clinical, scientific and technological advances are closely linked.
CardioFunxion offers four European industrial PhD positions
The PhD students who are interested in biomedical engineering and are awarded one of the four European industrial doctoral fellowships provided by the CardioFunXion programme will join one of the programme's four research lines and will be supervised by two principal investigators, one from UPF and one from Philips, and they will collaborate with the two partnering clinical centres, IDIBAPS and the University of Caen (France), for 18 months at each.
Further information and call: